Sandoz proposed biosimilars rituximab and etanercept recommended for approval in Europe*

World News: . []

Novartis International AG Sandoz proposed biosimilars rituximab and etanercept recommended for approval in
Europe*
Processed and transmitted by Nasdaq Corporate SolutionsThe issuer is solely responsible for the content of this announcement
...

More news and information about Novartis International AG

Published By:

Thomson Reuters: 18:43 GMT Friday 21st April 2017

Published: .

Search for other references to "sandoz" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers